Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Acute COPD Exacerbation with Ventilator Support
NCT01281748Phase 4Terminated
- Sponsor
- Hospital Universitario de Getafe
- Start
- Jul 2005
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone injection in chronic obstructive pulmonary disease (COPD), sponsored by Hospital Universitario de Getafe. Primary endpoints: Duration of mechanical ventilation and Need for intubation in patients treated with non-invasive mechanical ventilation. Started Jul 2005; status: terminated.
02
Drugs
methylprednisolone injection
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01281748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281748.